Published in J Hum Hypertens on August 02, 2007
Factors associated with treatment compliance in hypertension in southwest Nigeria. J Health Popul Nutr (2011) 1.13
Risk factors, quality of care and prognosis in South Asian, East Asian and White patients with stroke. BMC Neurol (2013) 0.80
Atrial Fibrillation and Race - A Contemporary Review. Curr Cardiovasc Risk Rep (2013) 0.80
30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies. PLoS One (2015) 0.79
Refugees and primary care: tackling the inequalities. BMJ (1998) 4.67
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J (1993) 4.28
Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med (1984) 2.93
Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32
Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood (2001) 2.27
Replacement of Aedes aegypti by Aedes albopictus in Mobile, Alabama. J Am Mosq Control Assoc (1991) 2.26
Localisation of enzymic defect in propionicacidaemia. Lancet (1970) 2.19
Fibrinogen: biochemistry, epidemiology and determinants. QJM (2003) 2.05
Antithrombotic therapy in hypertension: a Cochrane Systematic review. J Hum Hypertens (2005) 2.05
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. Heart (2008) 2.03
Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol (Oxf) (1993) 2.00
Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. J Intern Med (2014) 1.86
Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A (1997) 1.85
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Br J Cancer (2007) 1.78
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM (2007) 1.76
A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost (2011) 1.62
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol (2012) 1.60
Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C. Am J Transplant (2013) 1.58
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost (2012) 1.55
Cryoplasty for arterial restenosis. Eur J Vasc Endovasc Surg (2006) 1.54
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis. J Intern Med (2007) 1.53
Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project. Int J Clin Pract (2007) 1.50
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications. J Hum Hypertens (2012) 1.49
Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo. Blood (1999) 1.49
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol (1997) 1.47
Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplant Proc (2008) 1.46
Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J Acquir Immune Defic Syndr (1991) 1.45
Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost (2006) 1.45
Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases. Oncol Nurs Forum (1998) 1.44
Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States. JAMA (1990) 1.43
Development of electronic software for the management of trauma patients on the orthopaedic unit. Injury (2009) 1.43
Should oral glucose tolerance testing be mandatory following acute myocardial infarction? Int J Clin Pract (2007) 1.41
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia (2006) 1.41
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene (2006) 1.39
Reference ranges for plasma creatinine during the first month of life. Arch Dis Child (1983) 1.39
Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin? J Hum Hypertens (2008) 1.39
Educating medical students for work in culturally diverse societies. JAMA (1999) 1.37
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost (2010) 1.32
Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemost (2011) 1.31
Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med (1987) 1.27
Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res (2000) 1.26
Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. JAMA (1992) 1.25
Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol (1994) 1.23
Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens (2007) 1.23
Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort. J Thromb Haemost (2011) 1.23
The acetabular labral tear: an arthroscopic classification. Arthroscopy (1996) 1.22
Peripheral vascular disease and Virchow's triad for thrombogenesis. QJM (2002) 1.19
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Eur J Clin Invest (2003) 1.19
Ethnic monitoring and equity. BMJ (1995) 1.16
The N-terminal region of tapasin is required to stabilize the MHC class I loading complex. Eur J Immunol (1999) 1.13
Rate control in the medical management of atrial fibrillation. Heart (2006) 1.13
Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug Chem (1998) 1.12
Ethnic differences in blood pressure and the prevalence of hypertension in England. J Hum Hypertens (2002) 1.12
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost (2012) 1.11
The potential impact of periodontal disease on general health: a consensus view. Curr Med Res Opin (2008) 1.09
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol (2004) 1.07
A case of recurrent variceal bleeding in a non-cirrhotic patient. QJM (2010) 1.07
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart (2003) 1.06
AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol (1987) 1.06
Are elderly Asians in Britain at a high risk of vitamin D deficiency and osteomalacia? Age Ageing (1995) 1.06
Evolving characteristics of AIDS-related lymphoma. Blood (2000) 1.05
IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun (1994) 1.04
Assessment of tuberculosis burden in China using a dynamic disease simulation model. Int J Tuberc Lung Dis (2013) 1.04
Hospitalizations for respiratory syncytial virus infection in Alaska Native children. Pediatr Infect Dis J (1995) 1.04
Assessment of endothelial damage and dysfunction: observations in relation to heart failure. QJM (2003) 1.02
Protein degradation: the ins and outs of the matter. Curr Biol (1997) 1.01
Treatment of ocular adnexal Kaposi's sarcoma in acquired immune deficiency syndrome. Ophthalmology (1992) 1.01
Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Thromb Haemost (2013) 1.00
Improved detection of recurrent bladder cancer using the Bard BTA stat Test. Urology (1997) 1.00
Circulating endothelial cells: markers of vascular dysfunction. Clin Lab (2005) 1.00
Ocular adnexal Kaposi's sarcoma in acquired immunodeficiency syndrome. Am J Ophthalmol (1990) 1.00
Biomarkers in atrial fibrillation: an overview. Int J Clin Pract (2013) 0.99
Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Clin Cancer Res (2001) 0.99
Lone atrial fibrillation - an overview. Int J Clin Pract (2013) 0.98
Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report. Arch Ophthalmol (1994) 0.98
Thalassaemia in Britain: a tale of two communities. Births are rising among British Asians but falling in Cypriots. BMJ (1998) 0.98
Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. Virology (1986) 0.98
Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J (1991) 0.98
Learning for a multicultural society. Br J Gen Pract (1996) 0.97
Interleukin-10 gene expression in adult T-cell leukemia. Blood (1996) 0.96
The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM (2003) 0.96
Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Cancer Res (1999) 0.96
Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood (1989) 0.96
Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res (1996) 0.95
Quality of life in adults with congenital heart disease. Heart (2002) 0.95
Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation. J Thromb Haemost (2013) 0.95
Systolic vs diastolic blood pressure and the burden of hypertension. J Hum Hypertens (2002) 0.94
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension. Eur J Clin Invest (2005) 0.94
Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. Cancer Res (1999) 0.94
Primary cardiac lymphoma. Am J Clin Oncol (1991) 0.94
Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract (2011) 0.94
Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia. Int J Cardiol (2003) 0.93